OXINIUM◊ DH Total Hip Arthroplasty Pivotal Study

NCT02353377 · Status: ACTIVE_NOT_RECRUITING · Type: INTERVENTIONAL · Enrollment: 413

Last updated 2026-03-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to monitor safety of the participants implanted with the OXINIUM◊ DH Hip System up to 10-years post-implantation

Conditions

  • Hip Osteoarthritis

Interventions

DEVICE

OXINIUM DH Hip System

Investigational Group: OXINIUM DH Hip System

DEVICE

BIOLOX◊

Control Group: BIOLOX◊ delta ceramic heads and XLPE liners

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2021-09-21
Completion
2030-02-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353377 on ClinicalTrials.gov